SEC files complaint against Maxxon Inc.

We first told you Wednesday the Securities and Exchange Commission filed a complaint against Tulsa-based Maxxon Incorporated. <br><br>The SEC says Maxxon inflated its stock price by giving misleading

Thursday, January 2nd 2003, 12:00 am

By: News On 6

We first told you Wednesday the Securities and Exchange Commission filed a complaint against Tulsa-based Maxxon Incorporated.

The SEC says Maxxon inflated its stock price by giving misleading information about its safety syringe with a retractable needle.

Maxxon released a statement Thursday saying the allegations are wrong and it plans to fight the civil complaint.